Annals of Behavioral Medicine

, Volume 46, Issue 2, pp 243–250 | Cite as

Phone-Delivered Mindfulness Training for Patients with Implantable Cardioverter Defibrillators: Results of a Pilot Randomized Controlled Trial

  • Elena Salmoirago-Blotcher
  • Sybil L. Crawford
  • James Carmody
  • Lawrence Rosenthal
  • Gloria Yeh
  • Mary Stanley
  • Karen Rose
  • Clifford Browning
  • Ira S. Ockene
Brief Report

Abstract

Background

The reduction in adrenergic activity and anxiety associated with meditation may be beneficial for patients with implantable cardioverter defibrillators.

Purpose

This study aims to determine the feasibility of a phone-delivered mindfulness intervention in patients with defibrillators and to obtain preliminary indications of efficacy on mindfulness and anxiety.

Methods

Clinically stable outpatients were randomized to a mindfulness intervention (eight weekly individual phone sessions) or to a scripted follow-up phone call. We used the Hospital Anxiety and Depression Scale and the Five Facets of Mindfulness to measure anxiety and mindfulness, and multivariate linear regression to estimate the intervention effect on pre-post-intervention changes in these variables.

Results

We enrolled 45 patients (23 mindfulness and 22 control; age, 43–83; 30 % women). Retention was 93 %; attendance was 94 %. Mindfulness (beta = 3.31; p = 0.04) and anxiety (beta = −1.15; p = 0.059) improved in the mindfulness group.

Conclusions

Mindfulness training can be effectively phone-delivered and may improve mindfulness and anxiety in cardiac defibrillator outpatients.

Keywords

Mindfulness Anxiety Implantable cardioverter defibrillators Phone-delivery 

References

  1. 1.
    Moss AJ, Hall WJ, Cannom DS, et al. The Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.PubMedCrossRefGoogle Scholar
  2. 2.
    The Antiarrhythmics Versus Implantable Defibrillators Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1584.CrossRefGoogle Scholar
  3. 3.
    Moss AJ, Greenberg H, Case RB, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760-3765.PubMedCrossRefGoogle Scholar
  4. 4.
    Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.PubMedCrossRefGoogle Scholar
  5. 5.
    Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.PubMedCrossRefGoogle Scholar
  6. 6.
    Kamphuis HCM, de Leeuw JRJ, Derksen R, Hauer RNW, Winnubst JAM. Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: A prospective study. Europace. 2003;5:381-389.PubMedCrossRefGoogle Scholar
  7. 7.
    Schron EB, Exner DV, Yao Q, et al. Quality of life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105:589-594.PubMedCrossRefGoogle Scholar
  8. 8.
    Namerow P, Firth B, Heywood G, Windle J, Parides M. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: Findings form CABG PATCH trial. Pacing Clin Electrophysiol. 1999;22:1305-1313.PubMedCrossRefGoogle Scholar
  9. 9.
    Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Concerns about the implantable cardioverter defibrillator: A determinant of anxiety and depressive symptoms independent of experienced shocks. Am Heart J. 2005;149:664-669.PubMedCrossRefGoogle Scholar
  10. 10.
    Ladwig K-H, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: Results from the Prospective Living with an Implanted Cardioverter-Defibrillator Study. Arch Gen Psychiatry. 2008;65:1324-1330.PubMedCrossRefGoogle Scholar
  11. 11.
    Bostwick JM, Christopher LS. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Psychiatr Clin North Am. 2007;30:677-688.PubMedCrossRefGoogle Scholar
  12. 12.
    Magyar-Russell G, Thombs BD, Cai JX, et al. The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: A systematic review. J Psychosom Res. 2011;71:223-231.PubMedCrossRefGoogle Scholar
  13. 13.
    Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation. 1994;90:2225-2229.PubMedCrossRefGoogle Scholar
  14. 14.
    Nabi H, Hall M, Koskenvuo M, et al. Psychological and somatic symptoms of anxiety and risk of coronary heart disease: The Health and Social Support prospective cohort study. Biol Psychiatry. 2009;67:378-385.PubMedCrossRefGoogle Scholar
  15. 15.
    Sears SF, Vazquez LD, Matchett M, Pitzalis M. State-of-the-art: Anxiety management in patients with implantable cardioverter defibrillators. Stress Heal. 2008;24:239-248.CrossRefGoogle Scholar
  16. 16.
    Irvine J, Firestone J, Ong L, et al. A randomized controlled trial of cognitive behavior therapy tailored to psychological adaptation to an implantable cardioverter defibrillator. Psychosom Med. 2011;73:226-233.PubMedCrossRefGoogle Scholar
  17. 17.
    Crossmann A, Schulz SM, Kuhlkamp V, et al. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator. Psychosom Med. 2010;72:434-441.PubMedCrossRefGoogle Scholar
  18. 18.
    Salmoirago-Blotcher E, Ockene IS. Methodological limitations of psychosocial interventions in patients with an implantable cardioverter-defibrillator (ICD): A systematic review. BMC Cardiovasc Disord. 2009;9:56.PubMedCrossRefGoogle Scholar
  19. 19.
    Benson H. The relaxation response: Its subjective and objective historical precedents and physiology. Trends Neurosci. 1983;6:281-284.CrossRefGoogle Scholar
  20. 20.
    Benson H, Alexander S, Feldman C. Decreased premature ventricular contractions through use of the relaxation response in patients with stable ischaemic heart-disease. Lancet. 1975;2:380-382.PubMedCrossRefGoogle Scholar
  21. 21.
    Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: Theoretical considerations and preliminary results. Gen Hosp Psychiatry. 1982;4:33-47.PubMedCrossRefGoogle Scholar
  22. 22.
    Bohlmeijer E, Prenger R, Taal E, Cuijpers P. The effects of mindfulness-based stress reduction therapy on mental health of adults with a chronic medical disease: A meta-analysis. J Psychosom Res. 2010;68:539-544.PubMedCrossRefGoogle Scholar
  23. 23.
    Sullivan MJ, Wood L, Terry J, et al. The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): A mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am Heart J. 2009;157:84-90.PubMedCrossRefGoogle Scholar
  24. 24.
    Vijgen J, Botto G, Camm J, et al. Consensus statement of the European Heart Rhythm Association: Updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace. 2009;11:1097-1107.PubMedCrossRefGoogle Scholar
  25. 25.
    Salmoirago-Blotcher E, Carmody J, Yeh G, Crawford S, Rosenthal L, Ockene I. Design and methods for a pilot study of a phone-delivered, mindfulness-based intervention in patients with implantable cardioverter defibrillators. Evid Based Complement Alternat Med. 2012;2012:972106.PubMedCrossRefGoogle Scholar
  26. 26.
    Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983;140:734-739.PubMedGoogle Scholar
  27. 27.
    StataCorp. Stata Statistical Software, version 10. College Station, TX: StataCorp, LP, 2007.Google Scholar
  28. 28.
    Bellg AJ, Borrelli B, Resnick B, et al. Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23:443-451.PubMedCrossRefGoogle Scholar
  29. 29.
    Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006;13:27-45.PubMedCrossRefGoogle Scholar
  30. 30.
    Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361-370.PubMedCrossRefGoogle Scholar
  31. 31.
    Ingvar B, Alv AD, Tone Tangen H, Dag N. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res. 2002;52:69-77.CrossRefGoogle Scholar
  32. 32.
    Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25:333-341.PubMedCrossRefGoogle Scholar
  33. 33.
    Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355:1064-1069.PubMedCrossRefGoogle Scholar
  34. 34.
    Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems. Stat Med. 2002;21:2917-2930.PubMedCrossRefGoogle Scholar
  35. 35.
    Chuang-Stein C, Tong DM. The impact and implication of regression to the mean on the design and analysis of medical investigations. Stat Methods Med Res. 1997;6:115-128.PubMedCrossRefGoogle Scholar
  36. 36.
    Mace C. Mindfulness in psychotherapy: An introduction. Adv Psychiatr Treat. 2007;13:147-154.CrossRefGoogle Scholar
  37. 37.
    Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: A randomised controlled trial. Heart. 2003;89:155-160.PubMedCrossRefGoogle Scholar
  38. 38.
    Frizelle DJ, Lewin RJP, Kaye G, et al. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: A pilot study. Br J Health Psychol. 2004;9:381-392.PubMedCrossRefGoogle Scholar
  39. 39.
    Mohr DC, Vella L, Hart S, Heckman T, Simon G. The effect of telephone-administered psychotherapy on symptoms of depression and attrition: A meta-analysis. Clin Psychol. 2008;15:243-253.Google Scholar
  40. 40.
    Yeh GY, McCarthy EP, Wayne PM, et al. Tai chi exercise in patients with chronic heart failure: A randomized clinical trial. Arch Intern Med. 2011;171:750-757.PubMedCrossRefGoogle Scholar
  41. 41.
    Carmody J, Baer RA. Relationships between mindfulness practice and levels of mindfulness, medical and psychological symptoms and well-being in a mindfulness-based stress reduction program. J Behav Med. 2008;31:23-33.PubMedCrossRefGoogle Scholar
  42. 42.
    Nyklicek I, Kuijpers KF. Effects of mindfulness-based stress reduction intervention on psychological well-being and quality of life: Is increased mindfulness indeed the mechanism? Ann Behav Med. 2008;35:331-340.PubMedCrossRefGoogle Scholar
  43. 43.
    Grossman P. On measuring mindfulness in psychosomatic and psychological research. J Psychosom Res. 2008;64:405-408.PubMedCrossRefGoogle Scholar
  44. 44.
    Christopher M, Christopher V, Charoensuk S. Assessing Western mindfulness among Thai Theravada Buddhist monks. Ment Health Relig Cult. 2009;12:303-314.CrossRefGoogle Scholar

Copyright information

© The Society of Behavioral Medicine 2013

Authors and Affiliations

  • Elena Salmoirago-Blotcher
    • 1
  • Sybil L. Crawford
    • 2
  • James Carmody
    • 2
  • Lawrence Rosenthal
    • 1
  • Gloria Yeh
    • 3
  • Mary Stanley
    • 1
  • Karen Rose
    • 1
  • Clifford Browning
    • 1
  • Ira S. Ockene
    • 1
  1. 1.Division of Cardiovascular MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA
  2. 2.Division of Preventive and Behavioral MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA
  3. 3.Division of General Medicine and Primary Care, Beth Israel Deaconess Medical CenterHarvard Medical SchoolBostonUSA

Personalised recommendations